rs387907011
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_016097.5(IER3IP1):āc.62T>Gā(p.Val21Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000275 in 1,454,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. V21V) has been classified as Likely benign.
Frequency
Consequence
NM_016097.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IER3IP1 | NM_016097.5 | c.62T>G | p.Val21Gly | missense_variant | 1/3 | ENST00000256433.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IER3IP1 | ENST00000256433.6 | c.62T>G | p.Val21Gly | missense_variant | 1/3 | 1 | NM_016097.5 | P1 | |
IER3IP1 | ENST00000639845.1 | c.62T>G | p.Val21Gly | missense_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000212 AC: 5AN: 235702Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 128370
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1454620Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 722956
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Microcephaly, epilepsy, and diabetes syndrome 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 01, 2014 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 26, 2022 | Observed in compound heterozygous state in a patient with microcephaly, epilepsy, and neonatal diabetes; however, the variant in trans is of uncertain significance (Shalev et al., 2014); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 28915629, 28711742, 31589614, 34229114, 21835305, 24138066) - |
Microcephaly, epilepsy, and diabetes syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2021 | This sequence change replaces valine with glycine at codon 21 of the IER3IP1 protein (p.Val21Gly). The valine residue is moderately conserved and there is a moderate physicochemical difference between valine and glycine. This variant is present in population databases (rs387907011, ExAC 0.04%). This missense change has been observed in individuals with microcephaly with simplified gyral pattern, epilepsy, and permanent neonatal diabetes syndrome (PMID: 21835305, 24138066). ClinVar contains an entry for this variant (Variation ID: 30785). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at